ATM and colorectal carcinoma: Collectively, these findings underscore the pivotal role of autophagy in amplifying the anticancer effects of BMN673 in ATM-deficient CRC cells, reinforcing the notion that autophagy represents a crucial mediator of BMN673’s therapeutic efficacy.